Evidence Hub

Streptococcus pneumoniae serotype distribution and antimicrobial resistance profile in South Gujarat, India: Preliminary regional surveillance study

Patel JS, Naik JP, Munim FC, Italia YM, Desai DN

Indian journal of medical microbiology, 2026

Abstract

INTRODUCTION: Data on Streptococcus pneumoniae serotype distribution and antibiotic resistance in South Gujarat, India, are limited. This study investigated pneumococcal serotypes, antibiotic resistance patterns, and their associations with age and theoretical vaccine coverage.

METHODOLOGY: Among 550 processed clinical specimens, 27 (4.9%) yielded S. pneumoniae. Isolates were identified using VITEK 2 Compact, confirmed by conventional methods, tested for antimicrobial susceptibility, and serotyped. Age-wise serotype distribution and theoretical vaccine coverage were also analyzed.

RESULTS: High resistance was observed for erythromycin (89%), followed by tetracycline (67%), trimethoprim/sulfamethoxazole (59%), and clindamycin (48%). Lower resistance rates were observed for benzylpenicillin (22%), cefotaxime (22%), ceftriaxone (19%), levofloxacin (7%), and moxifloxacin (4%). All isolates were susceptible to vancomycin, tigecycline, rifampicin, chloramphenicol, and linezolid. Multidrug resistance (MDR) was observed in 67% of the pneumococcal isolates. MDR prevalence was highest (100%) among patients aged 45-65 years, whereas a lower MDR prevalence (40%) was observed among children aged 5-15 years. The S. pneumoniae 19F serotype was identified as the most predominant MDR serotype (26%), followed by serotypes 1 (11%), 3/9V/14/22F (7%), and 5/6A/6C/7B/10A/18C/19A/23B/24B (4%). The theoretical coverage rates of PCV7, PCV10, PCV13, Pneumosil, and PPSV23 were 44%, 59%, 74%, 63%, and…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free